Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gastrointestinal Diseases × S-1 plus cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1

Interventions

Fluorouracil 3 Bevacizumab 3 Oxaliplatin 2 Leucovorin 2 Irinotecan 2 trifluridine tipiracil drug combination 1 sintilimab 1 napabucasin 1 encorafenib 1 S-1 plus cisplatin 1 Paclitaxel 1 Oviposition 1 Levoleucovorin 1 Infliximab 1 Drug Therapy 1 Drainage 1 Cisplatin 1 Cetuximab 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02322593 2021-12-20

SOLAR

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed

711 enrolled 16 charts

Gastrointestinal

Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡